Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying potential germline variants from sequencing hematopoietic malignancies.

Hematology. American Society of Hematology. Education Program - 4 Dec 2020

Kraft Ira L, Godley Lucy A

Abstract excerpt

Next-generation sequencing (NGS) of bone marrow and peripheral blood increasingly guides clinical care in hematological malignancies. NGS data may help to identify single nucleotide variants, insertions/deletions, copy number variations, and translocations at a single time point, and repeated NGS testing allows tracking of dynamic changes in variants during the course of a patient's disease. Tumor cells used for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Aged
Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to Hematologic Neoplasms

Share to High-Throughput Nucleotide Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 33275754
DOI: 10.1182/hematology.2020006910
PMCID: PMC7727528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying potential germline variants from sequencing hematopoietic malignancies.PMID 33275754Read ↗

Identifying potential germline variants from sequencing hematopoietic malignancies.Semantic proximity Read ↗

Applications of next-generation sequencing in hematologic malignancies.Semantic proximity Read ↗

Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.Semantic proximity Read ↗

Incidental findings from cancer next generation sequencing panelsSemantic proximity Read ↗

Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.Semantic proximity Read ↗

Germline Genetic Predisposition to Hematologic Malignancy.Semantic proximity Read ↗

Current practices and guidelines for clinical next-generation sequencing oncology testing.Semantic proximity Read ↗

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profilingSemantic proximity Read ↗

Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.Semantic proximity Read ↗

Germline predisposition to hematopoietic malignancies.Semantic proximity Read ↗

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.Semantic proximity Read ↗

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.